mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.04 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.04 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
NSC23766 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.04 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.05 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.05 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.05 |